Is dopamine still the key to treating schizophrenia?

被引：0
|
作者：
Titmarsh, Steve
机构：
来源：
PROGRESS IN NEUROLOGY AND PSYCHIATRY | 2013年 / 17卷 / 04期
关键词：
D O I：
10.1002/pnp.290
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
Current antipsychotics are useful in treating schizophrenia but do not offer a complete solution to managing the illness. Recent research suggests that modifying targets upstream of dopamine receptor blockade may hold the key to an improved psychopharmacological approach, explained Dr Oliver Howes, Honorary Consultant Psychiatrist at the South London and Maudsley NHS Foundation Trust, speaking at a satellite symposium organised by Roche at the 12th Latest Advances in Psychiatry meeting in London in March. Steve Titmarsh reports. © 2013 John Wiley & Sons, Ltd.
引用
收藏
页码：21 / 22
页数：2
相关论文
共 50 条
  • [1] Dopamine partial agonists as an approach for treating schizophrenia
    Eriksson, E
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S406 - S406
  • [2] Timing still key to treating hypoxic ischaemic brain injury
    Gunn, Alistair J.
    Bennet, Laura
    LANCET NEUROLOGY, 2016, 15 (02): : 126 - 127
  • [3] NEUROSCIENCE - WILL NEW DOPAMINE-RECEPTORS OFFER A KEY TO SCHIZOPHRENIA
    TAUBES, G
    SCIENCE, 1994, 265 (5175) : 1034 - 1035
  • [4] In schizophrenia, some dopamine D-2-like receptors are still elevated
    Gjedde, A
    Reith, J
    Wong, DF
    PSYCHIATRY RESEARCH-NEUROIMAGING, 1996, 67 (02) : 159 - 161
  • [5] The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue
    Brisch, Ralf
    Saniotis, Arthur
    Wolf, Rainer
    Bielau, Hendrik
    Bernstein, Hans-Gert
    Steiner, Johann
    Bogerts, Bernhard
    Braun, Katharina
    Jankowski, Zbigniew
    Kumaratilake, Jaliya
    Henneberg, Maciej
    Gos, Tomasz
    FRONTIERS IN PSYCHIATRY, 2014, 5
  • [6] In schizophrenia, some dopamine D-2-like receptors are still elevated - Reply
    Nordstrom, AL
    Farde, L
    PSYCHIATRY RESEARCH-NEUROIMAGING, 1996, 67 (02) : 161 - 162
  • [7] Dopamine D3 receptor antagonism—still a therapeutic option for the treatment of schizophrenia
    Gerhard Gross
    Karsten Wicke
    Karla U. Drescher
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2013, 386 : 155 - 166
  • [8] Treating schizophrenia
    Haldane, Morgan
    Frangou, Sophia
    Argyropoulos, Spilios
    NEW SCIENTIST, 2007, 196 (2631) : 24 - 24
  • [9] Network Driven Discovery of Dopamine, Serotonin and Glutamate Receptors as Key Players in Schizophrenia
    Martha, Sushma Rani
    Patri, Manorama
    JOURNAL OF SCIENTIFIC & INDUSTRIAL RESEARCH, 2020, 79 (05): : 406 - 412
  • [10] DOPAMINE AND SCHIZOPHRENIA
    WILK, S
    STANLEY, M
    LANCET, 1977, 1 (8002): : 94 - 95
12345